Skip to content
S8694Senate2023-2024 SessionSame asA84

Label Pills by Appearance

Official title

“Relates to requiring prescription drug containers be labeled with a description of the size, shape, color and imprint of the prescription drug it contains”

Sponsor Cordell CleareSD-30Affects Education
Status
In Senate Committee
Higher Education
Impact
5/10
Moderate
Passage
0%

Bill progress

Step 2 of 7

In committee · Higher Education

What's happening

This bill requires prescription drug containers in New York to be labeled with a physical description of the drug, including size, shape, color, and imprint.

Why it matters

  1. Improves patient safety by helping individuals verify that the medication inside the container matches what was prescribed. , reducing the risk of medication errors due to mix-ups or pharmacy mistakes.

  2. Assists caregivers and those with visual impairments or literacy challenges. by providing clear, easily identifiable physical descriptions of medications, making it easier to distinguish between multiple prescriptions.

  3. Provides an additional safeguard against counterfeit or tampered drugs. by requiring labeling of unique drug characteristics (size, shape, color, imprint), helping both patients and pharmacists spot inconsistencies or anomalies.

The daily · weekday mornings

Albany, before your first meeting.

Every bill that moved yesterday, summarized in a sentence and ranked by impact. The Albany Scorecard follows on Sundays.

Free. Unsubscribe in one click. Want alerts on specific bills? Create an account.

Headline styles

Label Pills by Appearance

Plain English, a few words. Used as the page title.

Sponsors

Primary sponsor
Cordell Cleare

Senator · Senate District 30

Chair, Aging

No co-sponsors yet.

History

  1. Referred to higher education

Companion bill

The same bill in the other chamber. A bill becomes law when one version passes both houses and the governor signs it, so either number can carry it.

A84Assembly

Label Drug Shape and Color

In Assembly Committee · Higher Education · Sponsor Nader Sayegh

Impact 5 · Moderate0% to pass

Full text

1 pageUnderlined is new[Struck] is removedOfficial text on nysenate.gov ↗

STATE OF NEW YORK

8694

IN SENATE

March 1, 2024

Introduced by Sen. CLEARE -- read twice and ordered printed, and when printed to be committed to the Committee on Higher Education

AN ACT to amend the education law, in relation to requiring prescription drug containers be labeled with a description of the size, shape, color and imprint of the prescription drug it contains

The People of the State of New York, represented in Senate and Assembly, do enact as follows:

Section 1. Subdivision 1 of section 6810 of the education law, as amended by section 2 of part V of chapter 57 of the laws of 2012, is amended to read as follows:

1. No drug for which a prescription is required by the provisions of the Federal Food, Drug and Cosmetic Act or by the commissioner of health shall be distributed or dispensed to any person except upon a prescription written by a person legally authorized to issue such prescription. Such drug shall be compounded or dispensed by a licensed pharmacist, and no such drug shall be dispensed without affixing to the immediate container in which the drug is sold or dispensed a label bearing the name and address of the owner of the establishment in which it was dispensed, the date compounded, the number of the prescription under which it is recorded in the pharmacist's prescription files, the name of the prescriber, the name and address of the patient, a physical description of the drug including, but not limited to, the size, shape, color, and imprint of the drug, and the directions for the use of the drug by the patient as given upon the prescription. All labels shall conform to such rules and regulations as promulgated by the commissioner pursuant to section sixty-eight hundred twenty-nine of this article. The prescribing and dispensing of a drug which is a controlled substance shall be subject to additional requirements provided in article thirtythree of the public health law. The words "drug" and "prescription required drug" within the meaning of this article shall not be construed to include soft or hard contact lenses, eyeglasses, or any other device for the aid or correction of vision. Nothing in this subdivision shall prevent a pharmacy from furnishing a drug to another pharmacy which does not have such drug in stock for the purpose of filling a prescription.

§ 2. This act shall take effect on the ninetieth day after it shall have become a law.

EXPLANATION--Matter in italics (underscored) is new; matter in brackets

[ ] is old law to be omitted.

LBD01773-01-3

Reflowed for reading: line numbers and page breaks removed. Cite the official text.

Sponsor's memo

Title of bill

An act to amend the education law, in relation to requiring prescription drug containers be labeled with a description of the size, shape, color and imprint of the prescription drug it contains

Purpose or general idea of bill

Relates to requiring prescription drug containers be labeled with a description of the size, shape, color and imprint of the prescription drug it contains

Summary of provisions

Section 1 amends subdivision 1 of section 6810 of the Education Law, as amended by section 2 of part V of chapter 57 of the laws of 2012, estab- lishing how prescription drug containers are required to be labeled.

Section 2 sets the effective date.

Difference between original and amended version (if applicable)

N/A

Justification

According to a study published in the American Journal of Managed Care, a peer-reviewed medical journal, over half (51%) of all patient respond- ents taking drugs for chronic conditions including depression, diabetes, epilepsy, HIV, and hyperlipidemia, or hypertension reported having expe- rienced changes in the appearance of their generic drugs. Of these respondents who recognized a change, fewer than half reported having been notified of these changes, and approximately 12% reported stopping their medication or using it less frequently as a result of the change.

This legislation would require pharmacies to inform patients of any potential changes in their prescription drugs by requiring them to affix a label describing the size, shape, color and imprint of the prescription drug it contains in an effort to minimize medication nonad- herence and accidental overdoses or ingestion, both of which can lead to poor patient outcomes that cost billions of dollars in healthcare spend- ing nationwide annually on hospitalizations and other costs associated with disease progression.

Prior legislative history

2021-22: A5377-Referred to Higher Education

Fiscal implications for state and local governments

None

Effective date

This act shall take effect on the ninetieth day after it shall have become a law.

Summaries, headlines and scores are AI-generated from the official bill text. How we score bills. Source: NYS Open Legislation.